PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Cystitis, Interstitial D018856 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Decapitation D049248 2 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Ueno R et al. Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. 1982 Biochem. Biophys. Res. Commun. pmid:6960896
Fukushima M et al. 9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities. 1982 Biochem. Biophys. Res. Commun. pmid:6961920
Dieter P et al. Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages. 2000 Biochem. Biophys. Res. Commun. pmid:11027502
Tanaka K et al. Effects of prostaglandin D2 on helper T cell functions. 2004 Biochem. Biophys. Res. Commun. pmid:15044085
Onozaki A et al. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione. 2004 Biochem. Biophys. Res. Commun. pmid:15047143
Soares AF et al. Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. 2005 Biochem. Biophys. Res. Commun. pmid:16198309
Qureshi Z and Cagen LM Prostaglandins F2 alpha produced by rabbit renal slices is not a metabolite of prostaglandins E2. 1982 Biochem. Biophys. Res. Commun. pmid:6803799
Goto H et al. Age-associated decreases in prostaglandin contents in human gastric mucosa. 1992 Biochem. Biophys. Res. Commun. pmid:1510674
Satoh T et al. Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells. 1999 Biochem. Biophys. Res. Commun. pmid:10222233
Satarug S et al. Prostaglandin D2 induces heme oxygenase-1 mRNA expression through the DP2 receptor. 2008 Biochem. Biophys. Res. Commun. pmid:18957281
Keelan JA et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. 1999 Biochem. Biophys. Res. Commun. pmid:10471366
Shinozawa T et al. Tetranor PGDM analyses for the amyotrophic lateral sclerosis: positive and simple diagnosis and evaluation of drug effect. 2011 Biochem. Biophys. Res. Commun. pmid:22027143
Ehara N et al. Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1. 2004 Biochem. Biophys. Res. Commun. pmid:15358182
Erman A and Nasjletti A Enhancement of renal medulla prostaglandin synthetase activity by dexamethasone treatment in the rat. 1984 Biochem. Biophys. Res. Commun. pmid:6428405
Farrow B and Evers BM Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. 2003 Biochem. Biophys. Res. Commun. pmid:12535639
Yamamoto N et al. Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2. 1987 Biochem. Biophys. Res. Commun. pmid:3040001
Hirai H et al. Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor. 2003 Biochem. Biophys. Res. Commun. pmid:12878180
Kinoshita T et al. Predominance of prostaglandin D2 and I2 in the rat gastric mucosa--analysis by high-performance liquid chromatography. 1987 Biochem. Int. pmid:3555501
Diers AR et al. Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. 2010 Biochem. J. pmid:20536428
Sanchez-Rodriguez J et al. The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells. 2005 Biochem. J. pmid:15819613
García-Sáinz JA et al. Melittin stimulates liver glycogenolysis and the release of prostaglandin D2 and thromboxane B2. 1990 Biochem. J. pmid:2375756
vom Dahl S et al. Stimulation of release of prostaglandin D2 and thromboxane B2 from perfused rat liver by extracellular adenosine. 1990 Biochem. J. pmid:2396991
Rodway HA et al. Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells. 2004 Biochem. J. pmid:15171682
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Smith JB et al. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. 1992 Biochem. J. pmid:1375452
Ashraf M et al. Cross-linking of the high-affinity IgE receptor induces the expression of cyclo-oxygenase 2 and attendant prostaglandin generation requiring interleukin 10 and interleukin 1 beta in mouse cultured mast cells. 1996 Biochem. J. pmid:9003387
Landar A et al. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. 2006 Biochem. J. pmid:16268779
Shiraki T et al. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting. 2006 Biochem. J. pmid:16236024
Ricart KC et al. The permissive role of mitochondria in the induction of haem oxygenase-1 in endothelial cells. 2009 Biochem. J. pmid:19161347
Casteleijn E et al. Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. 1988 Biochem. J. pmid:3162673
Williams KA et al. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. 1987 Biochem. J. pmid:2444206
Casteleijn E et al. Conditioned media of Kupffer and endothelial liver cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins. 1988 Biochem. J. pmid:3166374
Thomson AM et al. Sequence, catalytic properties and expression of chicken glutathione-dependent prostaglandin D2 synthase, a novel class Sigma glutathione S-transferase. 1998 Biochem. J. pmid:9657971
Takahashi S et al. Localization of a cyclopentenone prostaglandin to the endoplasmic reticulum and induction of BiP mRNA. 1998 Biochem. J. pmid:9742210
Levonen AL et al. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. 2004 Biochem. J. pmid:14616092
Brass EP and Garrity MJ Structural specificity for prostaglandin effects on hepatocyte glycogenolysis. 1990 Biochem. J. pmid:2158311
Oh JY et al. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. 2008 Biochem. J. pmid:18237271
Bushfield M et al. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. 1985 Biochem. J. pmid:3002327
Diers AR et al. Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. 2010 Biochem. J. pmid:19916962
Neuschäfer-Rube F et al. Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor. 2003 Biochem. J. pmid:12519077
Kuiper J et al. Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells. 1989 Biochem. J. pmid:2818563
Pandey HP et al. Concentration of prostaglandin D2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats. 1995 Biochem. Mol. Biol. Int. pmid:8595382
Fowler CJ and Tiger G Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro. 2005 Biochem. Pharmacol. pmid:15794945
Jacobsen S et al. Synergism between thapsigargin and the phorbol ester 12-O-tetradecanoylphorbol 13-acetate on the release of [14C]arachidonic acid and histamine from rat peritoneal mast cells. 1987 Biochem. Pharmacol. pmid:2435291
Fernández-Tome M et al. COX-2-mediated PGD2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue. 2004 Biochem. Pharmacol. pmid:14698037
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Koyani CN et al. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death. 2016 Biochem. Pharmacol. pmid:26801686
Ko FN et al. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr. 1993 Biochem. Pharmacol. pmid:8216367
Gresele P et al. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. 1984 Biochem. Pharmacol. pmid:6430299
Cossette C et al. Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes. 2015 Biochem. Pharmacol. pmid:26032638
Emi M and Maeyama K The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. 2004 Biochem. Pharmacol. pmid:15013841
Chbicheb S et al. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. 2011 Biochem. Pharmacol. pmid:21338579
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Ikai K et al. Inhibitory effect of tranilast on prostaglandin D synthetase. 1989 Biochem. Pharmacol. pmid:2475113
MacDermot J Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo. 1986 Biochem. Pharmacol. pmid:2427086
Yamamoto S et al. Agents that elevate cyclic AMP induce receptor phosphorylation primarily at serine 331 in HEK 293 cells overexpressing human thromboxane receptor alpha. 2002 Biochem. Pharmacol. pmid:12147288
Surh YJ et al. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. 2011 Biochem. Pharmacol. pmid:21843512
Lu Y et al. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. 2011 Biochem. Pharmacol. pmid:21907188
Liu C et al. 15d-PGJâ‚‚ decreases PGEâ‚‚ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter. 2014 Biochem. Pharmacol. pmid:25108236
Tao H and Hajri T Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists. 2011 Biochem. Pharmacol. pmid:21924248
Faili A et al. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha. 1993 Biochem. Pharmacol. pmid:8388209
Koizumi T et al. Inhibitory effect of an intracellular glutathione on delta 12-prostaglandin J2-induced protein syntheses in porcine aortic endothelial cells. 1992 Biochem. Pharmacol. pmid:1417983
Endo S et al. Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin Dâ‚‚, and other endogenous and xenobiotic carbonyl compounds. 2013 Biochem. Pharmacol. pmid:23994167
Xue L et al. Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2). 2007 Biochem. Pharmacol. pmid:17196174
Quraishi O et al. Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids. 2002 Biochem. Pharmacol. pmid:11931852
Casali CI et al. Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells. 2014 Biochem. Pharmacol. pmid:24915420
Woodward DF and Lawrence RA Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells. 1994 Biochem. Pharmacol. pmid:8185669
Robinson C et al. The metabolism of prostaglandin D2. Evidence for the sequential conversion by NADPH and NAD+ dependent pathways. 1989 Biochem. Pharmacol. pmid:2818626
Koizumi T et al. Activation of heat shock transcription factors by delta 12-prostaglandin J2 and its inhibition by intracellular glutathione. 1993 Biochem. Pharmacol. pmid:8328983
Hoult JR et al. Organ selective conversion of prostaglandin D2 to 9 alpha, 11 beta-prostaglandin F2 and its subsequent metabolism in rat, rabbit and guinea pig. 1988 Biochem. Pharmacol. pmid:3178873
Schuligoi R et al. PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors. 2007 Biochem. Pharmacol. pmid:17452035
Kim EH and Surh YJ The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. 2008 Biochem. Pharmacol. pmid:18771658
Kim JW et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. 2008 Biochem. Pharmacol. pmid:18775681
Gebicke-Haerter PJ et al. Pertussis and cholera toxins inhibit prostaglandin synthesis in rat astrocyte cultures at distinct metabolic steps. 1991 Biochem. Pharmacol. pmid:1909527
Cocca C et al. 15-Deoxi-Delta(12,14)-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest. 2009 Biochem. Pharmacol. pmid:19576185
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Richelsen B Relationship between binding and action of different prostaglandins in rat adipocytes with special reference to PGE2 and PGI2. 1987 Biochem. Pharmacol. pmid:2825710
Koizumi T et al. Induction of a 31,000-dalton stress protein by prostaglandins D2 and J2 in porcine aortic endothelial cells. 1991 Biochem. Pharmacol. pmid:1867634
Coyle AT and Kinsella BT Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. 2006 Biochem. Pharmacol. pmid:16499875
Kanda N et al. Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes. 2010 Biochem. Pharmacol. pmid:19925780
Crivellari MT et al. Eicosanoid release and mepyramine, LTC4 and LTD4 binding in passively sensitized human lung parenchyma in vitro. 1991 Biochem. Pharmacol. pmid:1859453
Liu JY et al. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. 2010 Biochem. Pharmacol. pmid:19896470
Kim EH and Surh YJ 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. 2006 Biochem. Pharmacol. pmid:16987499
Harbige LS et al. Cytokine secretion by human T cell clones is differentially regulated by eicosanoids. 1997 Biochem. Soc. Trans. pmid:9191392
Emmans VC et al. Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. 2004 Biochem. Soc. Trans. pmid:15494029
Ward C et al. Regulation of granulocyte apoptosis by NF-kappaB. 2004 Biochem. Soc. Trans. pmid:15157161
Atsmon J et al. Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. 1990 Biochemistry pmid:2340271
Lin Q et al. Ligand selectivity of the peroxisome proliferator-activated receptor alpha. 1999 Biochemistry pmid:9890897
Paumi CM et al. Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2). 2004 Biochemistry pmid:14979731
Boutaud O et al. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid. 2001 Biochemistry pmid:11389610
Li H et al. Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes. 2010 Biochemistry pmid:20853849
Aldini G et al. Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. 2007 Biochemistry pmid:17297918
Carrier EJ et al. Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA. 2014 Biochemistry pmid:24684440
Renedo M et al. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. 2007 Biochemistry pmid:17489560
Shibata T et al. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome. 2003 Biochemistry pmid:14636064
Paumi CM et al. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. 2003 Biochemistry pmid:12731885
Reich EE et al. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. 2000 Biochemistry pmid:10694406
Prage EB et al. Observation of two modes of inhibition of human microsomal prostaglandin E synthase 1 by the cyclopentenone 15-deoxy-Δ(12,14)-prostaglandin J(2). 2012 Biochemistry pmid:22356188
Pérez S et al. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. 2006 Biochim. Biophys. Acta pmid:16545597
Buechler C et al. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. 2001 Biochim. Biophys. Acta pmid:11420178